Common use of Absence of Litigation Clause in Contracts

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 225 contracts

Samples: Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Sincerity Applied Materials Holdings Corp.)

AutoNDA by SimpleDocs

Absence of Litigation. Except as disclosed in the Company’s public filingsPeriodic Report filings with the SEC, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 146 contracts

Samples: Securities Purchase Agreement (Blackstar Enterprise Group, Inc.), Securities Purchase Agreement (MyDx, Inc.), Securities Purchase Agreement (NightFood Holdings, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 45 contracts

Samples: Securities Purchase Agreement (FLASR, Inc.), Securities Purchase Agreement (Thinspace Technology, Inc.), Securities Purchase Agreement (Friendable, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.

Appears in 37 contracts

Samples: Securities Purchase Agreement (NanoFlex Power Corp), Securities Purchase Agreement (Sirrus Corp.), Securities Purchase Agreement (Lithium Exploration Group, Inc.)

Absence of Litigation. Except as disclosed to the Buyer or in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoingMaterial Adverse Effect.

Appears in 27 contracts

Samples: Securities Purchase Agreement (Agritek Holdings, Inc.), Securities Purchase Agreement (Agritek Holdings, Inc.), Securities Purchase Agreement (Propanc Biopharma, Inc.)

Absence of Litigation. Except as disclosed in the Company’s 's public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 14 contracts

Samples: Securities Purchase Agreement (Guided Therapeutics Inc), Securities Purchase Agreement (Medican Enterprises, Inc.), Securities Purchase Agreement (Start Scientific, Inc.)

Absence of Litigation. Except as disclosed set forth in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 9 contracts

Samples: Securities Purchase Agreement (Growlife, Inc.), Securities Purchase Agreement (Titan Iron Ore Corp.), Securities Purchase Agreement (True Nature Holding, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filingsset forth on Schedule 3(i), there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 8 contracts

Samples: Securities Purchase Agreement (Camelot Entertainment Group, Inc.), Securities Purchase Agreement (Camelot Entertainment Group, Inc.), Securities Purchase Agreement (Camelot Entertainment Group, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 6 contracts

Samples: Securities Purchase Agreement (Pura Naturals, Inc.), Securities Purchase Agreement (Green Automotive Co), Securities Purchase Agreement (Pura Naturals, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings's Periodic Report filings with the SEC, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 6 contracts

Samples: Securities Purchase Agreement (Cannasys Inc), Securities Purchase Agreement (U.S. Lithium Corp.), Securities Purchase Agreement (Rostock Ventures Corp)

Absence of Litigation. Except as disclosed in the Company’s public filingsDisclosure Schedule hereto, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 6 contracts

Samples: Securities Purchase Agreement (HydroPhi Technologies Group, Inc.), Securities Purchase Agreement (HydroPhi Technologies Group, Inc.), Securities Purchase Agreement (HydroPhi Technologies Group, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 5 contracts

Samples: Securities Purchase Agreement (Freeseas Inc.), Securities Purchase Agreement (Freeseas Inc.), Securities Purchase Agreement (Freeseas Inc.)

Absence of Litigation. Except as disclosed in Schedule 3(i-1), to the Company’s public filingsknowledge of the Company or any of its subsidiaries, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f3(i-2) contains a complete list and summary description of any known pending or, to the knowledge of the Company, or threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it it, if adversely decided, would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 4 contracts

Samples: Securities Purchase Agreement (Universal Energy Corp.), Securities Purchase Agreement (Universal Energy Corp.), Securities Purchase Agreement (Universal Energy Corp.)

Absence of Litigation. Except Other than as disclosed set forth in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effecteffect on the Company. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 3 contracts

Samples: Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (C-Bond Systems, Inc), Securities Purchase Agreement (C-Bond Systems, Inc)

Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Except as disclosed on Schedule 3(i) the Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Xsovt Brands, Inc.), Securities Purchase Agreement (Xsovt Brands, Inc.)

Absence of Litigation. Except as otherwise disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Mphase Technologies Inc), Securities Purchase Agreement (Mphase Technologies Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Material Adverse Effect, except as set forth in the SEC Documents.. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding (which would require disclosure on the Company’s SEC Documents) against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Jammin Java Corp.), Securities Purchase Agreement (Jammin Java Corp.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the best knowledge of the Company or any of its subsidiariesCompany, (i) threatened against or affecting the Company Company, its subsidiary, or any of its subsidiaries, or their the officers or directors of the Company or its subsidiary in their capacity capacities as suchsuch or (ii) that questions the validity of the Transaction Documents or the right of the Company to enter into or perform the Transaction Documents, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of nor is there any litigation pending or, to the knowledge of the Company's knowledge, threatened proceeding threat thereof, against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any subsidiary by reason of the foregoingactivities presently conducted or proposed to be conducted by the Company or its subsidiary, nor, to the Company’s knowledge, is there any basis therefor.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Guided Therapeutics Inc), Securities Purchase Agreement (Guided Therapeutics Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list from the Company and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Hemp Naturals, Inc.), Securities Purchase Agreement (Hemp Naturals, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Lithium Exploration Group, Inc.), Securities Purchase Agreement (Lithium Exploration Group, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, other than disclosed in the SEC Documents, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Freeseas Inc.), Securities Purchase Agreement (Freeseas Inc.)

Absence of Litigation. Except Other than as disclosed in the Company’s public filingsset forth on Schedule 3(i), there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Net TALK.COM, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains The Company’s public filings contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)

Absence of Litigation. Except as disclosed in the Company’s 's public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cannabis Global, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect except as set forth in the SEC Documents. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Sanomedics International Holdings, Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect (except with respect to the lawsuit brought against the Company by its previous controller). Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries involving estimated damages in excess of $200,000, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Guided Therapeutics Inc)

Absence of Litigation. Except as disclosed in the Company’s public filingsfilings with the SEC, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) The Company’s public filings with the SEC contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)

AutoNDA by SimpleDocs

Absence of Litigation. Except as disclosed in the Company’s public filingsSchedule 3(i), there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Except as set forth in Schedule 3(i), the Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Sti Group Inc)

Absence of Litigation. Except as disclosed set forth in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might could reasonably give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (EzFill Holdings Inc)

Absence of Litigation. Except Other than as disclosed in the Company’s public filings, 's SEC Documents there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Pervasip Corp)

Absence of Litigation. Except as disclosed in the Company’s 's public filings, there is no action, suit, claim, proceeding, inquiry inquiry, or investigation before or by any court, public board, government agency, or self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which that might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cannasys Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no official action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect except as stated in the Company's Foini 10-K and 10-Q filings with the SEC. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (BioNeutral Group, Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no official action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect except as stated in the Company’s Form 10-K and 10-Q filings with the SEC. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (BioNeutral Group, Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) The Company’s filings with the SEC contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Rich Pharmaceuticals, Inc.)

Absence of Litigation. Except as disclosed to the Buyer or in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(t) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoingMaterial Adverse Effect.

Appears in 1 contract

Samples: Securities Purchase Agreement (Propanc Biopharma, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect except as disclosed in the SEC Documents. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Sanomedics International Holdings, Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public is board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. effect The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (NanoFlex Power Corp)

Absence of Litigation. Except as disclosed in the Company’s public filingsSEC Documents, there tthere is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f) contains The public filings contain a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (TPT Global Tech, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filingspublicfilings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances circumstances, which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (IRONCLAD ENCRYPTION Corp)

Absence of Litigation. Except as disclosed in the Company’s ’ s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened tlu·eatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (NanoFlex Power Corp)

Absence of Litigation. Except Other than as disclosed in the Company’s public filingsSEC Documents, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (RespireRx Pharmaceuticals Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing, except as disclosed in Schedule 3(f).

Appears in 1 contract

Samples: Securities Purchase Agreement (Clearday, Inc.)

Absence of Litigation. Except as disclosed in the Company’s public filings, there is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiaries, threatened against or affecting the Company or any of its subsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effect. Schedule 3(f3(t) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiaries, without regard to whether it would have a material adverse effect. The Company and its subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Guided Therapeutics Inc)

Absence of Litigation. Except as disclosed in the Company’s public filings, there There is no action, suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company or any of its subsidiariesSubsidiaries, threatened against or affecting the Company or any of its subsidiariesSubsidiaries, or their officers or directors in their capacity as such, that could have a material adverse effectMaterial Adverse Effect. To the extent not already disclosed in the SEC Documents, Schedule 3(f3(i) contains a complete list and summary description of any pending or, to the knowledge of the Company, threatened proceeding against or affecting the Company or any of its subsidiariesSubsidiaries, without regard to whether it would have a material adverse effectMaterial Adverse Effect. The Company and its subsidiaries Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

Appears in 1 contract

Samples: Securities Purchase Agreement (Blue Sphere Corp.)

Time is Money Join Law Insider Premium to draft better contracts faster.